Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
There you go folks...as predicted yesterday , this RNS was going to be hot on the heels of yesterdays,
Virolens® registration received in Great Britain
Fri, 26th Mar 2021 07:00
RNS Number : 5704T
TT Electronics PLC
26 March 2021
26 March 2021
TT Electronics plc
Virolens® registration received in Great Britain
Further to the announcement on 25 March 2021, TT Electronics plc ("TT") confirms that the Medicines and Healthcare products Regulatory Authority ("MHRA"), which is responsible for ensuring that medical devices meet applicable standards of safety, quality and efficacy, has registered Virolens® for use and sale in Great Britain and iAbra has been granted Certificates of Free Sale ("CFS").
This is a welcome milestone in the development of the Virolens technology.
Virolens® is a rapid COVID-19 screening device for which TT is the exclusive manufacturing partner.
Revenues to TT from the sale of Virolens following the MHRA approval are dependent on iAbra's potential end customers in Great Britain converting expressions of interest into firm orders.
A high proportion of the commercial interest in Virolens to date has been outside of Great Britain and any revenues resulting from this interest require further regulatory approval in those territories.
There continues to be a wide range of potential commercial outcomes and hence no certainty as to the financial impact on TT.
Conpention , Share price predictions at 12pm
Ill go for 3.20
This is a big announcement - well done long term holders. If not today it will happen eventually
£3 really
2pounds seventy two and a half pence
This is a huge long term revenue generator for TTG. They will need to scale up to meet demand!
Massive deal!
As for the SP well BlackRock won’t be selling now and Schroeder’s broker will be all over any float. The impact of this income on the SP will be transformational even if you just take UK cruise ships and UK airports.
Europe and US will follow but we simply won’t be able to meet demand.
£3.50 today. £5 very quickly. A safe long term divi from this level for investors.
Tip a few more stocks into here while you can!
I just wish AVCT got a flipping wiggle on!
Trek
Just got some at 237! No idea why the the SP hasn’t spiked, we are only a £400m mcap!
Oh well, pretty good bet from this level one would like to think. Last time we hit 290 on a rumour!
Lol!
Trek
Very blindsided chatboard avct, ive got a substantial pot in that too but theyve been very dismissive of my flagging of ttg so stuffem
looking good here, has there been data released on sensitivty/specificity? can't find it in RNS
tsales. Virolens has a 100% sensitivity and 99.4% specificity
Hi Jonathon, do you know where this data is from? Thanks.
Histate, which is distributing the test, said it would
launch with immediate effect following the approval in the UK by
the Medicines and Healthcare products Regulatory Agency (MHRA),
and was hoping for a further rollout in coming months.
Histate said trials had indicated the test had 98.1%
sensitivity, meaning it returns few false negatives, and 99.7%
specificity, meaning few false positives.
rmiller. https://virolens.keyoptions.com/
can see this doing well
LONDON, March 26 (Reuters) - Britain's medicine regulator
has approved a 20-second COVID-19 test, the product's
distributor said on Friday as it launched a testing system it
said could be used in airports, sports venues and businesses.
Rapid tests are seen as a key plank of Prime Minister Boris
Johnson's roadmap out of lockdown, but concerns have been
expressed about the accuracy of existing lateral flow devices.
The Virolens test, which is made by British start-up iAbra
and TT Electronics, has been trialled at Heathrow Airport, and
uses swabs of saliva.
Histate, which is distributing the test, said it would
launch with immediate effect following the approval in the UK by
the Medicines and Healthcare products Regulatory Agency (MHRA),
and was hoping for a further rollout in coming months.
Histate said trials had indicated the test had 98.1%
sensitivity, meaning it returns few false negatives, and 99.7%
specificity, meaning few false positives.
(Reporting by Alistair Smout, Editing by Paul Sandle)